Catalog Number | : | CS-P-08463 |
---|---|---|
CAS Number | : | 1025967-78-5 (Unlabeled) |
Status | : | Available |
List Price | Online Price | Size | Stock Status | Quantity | |
---|---|---|---|---|---|
![]() |
Chemical Name | : | Lifitegrast D4 |
---|---|---|
Category | : | Isotope Labelled Compounds |
Molecular Weight | : | 619.50 g/mol mol/g |
Molecular Formula | : | C29H20D4Cl2N2O7S |
Status: | : | Available |
---|---|---|
COA | : |
[Login Needed]
|
MSDS | : |
[Login Needed]
|
Payment mode | : | Credit / Debit / Purchase Order |
---|---|---|
Taxes | : | All prices are inclusive taxes |
Refund Policy | : | 30 days money back guarantee |
Canonical SMILES | : | CS(=O)(=O)C1=CC=CC(=C1)CC(C(=O)O)NC(=O)C2=C(C=C3CN(CCC3=C2Cl)C(=O)C4=CC5=C(C=C4)C=CO5)Cl |
---|---|---|
Isomeric SMILES | : | CS(=O)(=O)C1=CC=CC(=C1)C[C@@H](C(=O)O)NC(=O)C2=C(C=C3CN(CCC3=C2Cl)C(=O)C4=CC5=C(C=C4)C=CO5)Cl |
InChI | : | InChI=1S/C29H24Cl2N2O7S/c1-41(38,39)20-4-2-3-16(11-20)12-23(29(36)37)32-27(34)25-22(30)13-19-15-33(9-7-21(19)26(25)31)28(35)18-6-5-17-8-10-40-24(17)14-18/h2-6,8,10-11,13-14,23H,7,9,12,15H2,1H3,(H,32,34)(H,36,37)/t23-/m0/s1 |
InchIKey | : | JFOZKMSJYSPYLN-QHCPKHFHSA-N |
IUPAC Name | : | (2S)-2-[[2-(1-benzofuran-6-carbonyl)-5,7-dichloro-3,4-dihydro-1H-isoquinoline-6-carbonyl]amino]-3-(3-methylsulfonylphenyl)propanoic acid |
Exact Mass | : | 614.0681277 |
Solubility | : | Soluble |
Use Classification | : | Human Drugs -> EU pediatric investigation plans |
Hazard Class | : | Repr. 2 (100%) |
Description | : | Lifitegrast is an N-acyl-L-alpha-amino acid obtained by formal condensation of the carboxy group of N-[2-(1-benzofuran-6-carbonyl)]-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid with the amino group of 3-(methanesulfonyl)-L-phenylalanine. Used for treatment of keratoconjunctivitis sicca (dry eye syndrome). It has a role as an anti-inflammatory drug and a lymphocyte function-associated antigen-1 antagonist. It is a L-phenylalanine derivative, a sulfone, a N-acyl-L-alpha-amino acid, a member of isoquinolines and a member of 1-benzofurans. |
EC Number | : | 813-044-8 |
Toxicity Summary | : | Some adverse effects in 5-25% of the patients include instillation site irritation, dysgeusia and reduced visual acuity. There is no evidence or reports of potential carcinogenic, mutagenic or fertility-altering effects of this drug. |